Latanoprost TOA Ophthalmic Solution 0.005% w/v Mechanism of Action

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Action

Pharmacology: Bioequivalence study: After a single instillation of LATANOPROST TOA OPHTHALMIC SOLUTION 0.005% W/V or its standard preparation (ophthalmic solution 0.005%) was administered into the conjunctival sac of both eyes of healthy adult men, the IOP was measured, and the obtained parameters (maximum IOP difference between before and after instillation, area under the curve of IOP versus time area under IOP curve) were statistically analyzed. As a result, bioequivalence of both drugs was confirmed. (See Table 1 and Figures 1 and 2.)

Click on icon to see table/diagram/image

Click on icon to see table/diagram/image

Parameters of IOP, maximum IOP difference, and area under the curve of IOP versus time may vary depending on the test conditions of subject selection, the number of IOP measurements, and the measurement time of IOP.

Latanoprost TOA Ophthalmic Solution 0.005% w/v Mechanism of Action

latanoprost

Manufacturer:

Nitto Medic

Distributor:

Primal